Abstract
Lewis lung (3LL) peritoneal carcinomatosis elicits a complex host response in the peritoneal compartment. The response was delayed, showing few inflammatory cells through day 6 after lethal challenge with 3LL cells. Responses began in about half the mice on day 7 and had appeared in all mice by day 11. On day 7, some mice still showed no detectable 3LL growth in the peritoneal lavage fluid, and no differences in the peritoneal cell populations as compared with the control group. Other tumor-bearing mice, however, had evidence of 3LL cells and hemorrhagic ascites in the peritoneal compartment, with increased numbers of peritoneal macrophages (PM) and polymorphonuclear neutrophils (PMN). By day 11, all tumor-bearing mice had 3LL growth and hemorrhagic ascites. On days 7–11, there was a major influx of macrophages with a later influx of PMN between days 11 and 14. Two distinct PM populations were detected on day 7 in mice that showed detectable 3LL peritoneal carcinomatosis: resident PM, which did not express the Mac-2 antigen, and recruited PM, which were Mac-2+. At least some resident PM remained in the peritoneal compartment through day 14. Analysis of the kinetics of the cytotoxic capabilities of PM from tumor-bearing mice showed that by day 7 macrophages were able to kill the B16 melanoma tumor target, but not the 3LL target. The PM, however, were able to be activated further to kill the 3LL target by treatment in vitro with lipopolysaccharide and interferon γ. No inhibition of PM tumoricidal activity could detected in the peritoneal wash of tumor-bearing mice. A lack of activation of PM from 3LL tumor-bearing mice may be involved in progression of peritoneal carcinomatosis.
Similar content being viewed by others
References
Askew D, Burger CJ, Elgert KD (1990) Modulation of alloreactivity by Mac-1+, −2+, and −3+ macrophages from normal and tumor-bearing hosts: flow cytofluorometrically separated macrophages. Immunobiology 182:1
Austyn JM, Gordon S (1981) F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 11:805
Baggiolini MA, Walz A, Kunkel SL (1989) Neutrophil-activating protein-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 84: 1045
Botazzi B, Polentarutti N, Acero R, Balsari A, Boraschi D, Ghezzi P, Salmona M, Mantovani A (1983) Regulation of the macrophage content of neoplasms by chemoattractants. Science 220: 210
Brodt P (1986) Characterization of two highly metastatic variants of Lewis lung carcinoma with different organ specificities. Cancer Res 46: 2442
Bugelski PJ (1985) Sequential histochemical staining for resident and recruited macrophages. J Leukocyte Biol 38: 687
Dempsey WL, Smith AL, Morahan PS (1986) Effect of inapparent murine hepatitis virus infections on macrophages and host resistance. J Leukocyte Biol 39: 559
Duffie GP, Young MRI (1991) Tumoricidal activity of alveolar and peritoneal macrophages of C57B1/6 mice bearing metastatic or nonmetastatic variants of Lewis Lung carcinoma. J Leukocyte Biol 49: 8
Dullens HF, Walraven R van, Klomberg M, Rademakers JPHM, Goey ICE de, Otter W den (1988) Lack of correlation between in vivo peroxidatic activity patterns and tumoricidal activity in vitro of peritoneal macrophages after intraperitoneal immunization with tumor cells. Immunobiology 177: 293
Fauve RM, Hevin B, Jacob H, Gaizzard JA, Jacob F (1979) Antiinflammatory effects of murine malignant cells. Proc Natl Acad Sci USA 10: 4052
Fecchio D, Sirois P, Russo M, Jancar S (1990) Studies on inflammatory response induced by Ehrlich tumor in mice peritoneal cavity. Inflammation 14: 125
Fisher FI, Young RC (1977) Advances in the staging and treatment of ovarian cancer. Cancer 39: 967
Gorelik E, Wiltrout RH, Brunda MJ, Holden HT, Herberman RB (1982) Augmentation of metastasis formation by thioglycollate-elicited macrophages. Int J Cancer 29: 575
Haskill S, Becker S (1985) Disappearance and reappearance of resident macrophages: importance inC. parvum-induced tumoricidal activity. Cell Immunol 90: 179
Ho MK, Springer TA (1982) Mac-2, a novel 32,000 Mr mouse macrophage subpopulation specific antigen defined by monoclonal antibodies. J Immunol 128: 1221
Jones EJ, Lee TE, Skinner W, Koyama P, Prescott D (1984) Absence of generalized immunosuppression in C57BL/6J mice implanted with Lewis T241 fibrosarcoma or Lewis lung carcinoma. Cancer Immunol Immunother 18: 82
Jones PDE, Castro JE (1977) Immunological mechanisms in metastatic spread and the antimetastatic effects ofC. parvum. Br J Cancer 35: 519
Keller R, Keist R, Frei K (1990) Lymphokines and bacteria, that induce tumoricidal activity, trigget a different secretory response in macrophages. Eur J Immunol 20: 695
Mantovani A, Botazzi B, Colotta F, Sozzani S, Ruco L (1992) The origin and function of tumor-associated macrophages. Immunol Today 13: 239
Loveless SE, Hepner GH (1983) Tumor-associated macrophages in mouse mammary tumors. I. Differential cytotoxicity of macrophages from metastatic and nonmentastatic tumors. J Immunol 131: 2074
Markovic SN, Murasko DM (1990) Neoadjuvant immunotherapy with interferon of the spontaneously metastasizing murine B16F10 melanoma. Int J Cancer 45: 1013
Melnicoff MJ, Morahan PS, Jensen BD, Breslin EW, Horan PK (1988) In vivo labelling of resident peritoneal macrophages. J Leukocyte Biol 43: 387
Melnicoff MJ, Horan PK, Morahan PS (1989) Kinetics of changes in peritoneal cell populations following acute inflammation. Cell Immunol 118: 178
Meyers MA (1981) Intraperitoneal spread of malignancies and its effect on the bowel. Clin Radiol 32: 129
Morahan PS, Kaplan AM (1977) Macrophage-mediated tumor resistance. In: Control of neoplasia by modulation of the immune system. Raven Press, New York, p 449
Mukai M, Shinkai K, Tateishi R, Mori Y, Akedo H (1987) Macrophage potentiation of invasive capacity of rat ascites hepatoma cells. Cancer Res 47: 2167
Normann S, Besedovsky H, Schardt M, Rey A del (1991) On the mechanism of anti-inflammation induced by tumor transplantation, surgery, and irritant rejection. J Leukocyte Biol 49: 455
Pinto AJ, Morahan PS, Brinton MA (1988) Comparative study of various immunomodulators for macrophage and natural killer cell activation and antiviral efficacy against exotic RNA viruses. Int J Immunopharmacol 10: 197
Regelson W (1986) Advances in intraperitoneal (intracavitary) administration of synthetic polymers for immunotherapy and chemotherapy. J Bioact Compatible Polym 1: 84
Remels L, Neirynck A, Brys L, Vercauteren E, De Baetselier P (1989) TNF-α mediated selection of macrophage-resistant generegulatory tumor variants. Clin Exp Metastasis 7: 493
Remels L, Fransen L, Huygen K, De Baetselier P (1990) Poly I:C activated macrophages are tumoricidal for TNF-α-resistant 3LL tumor cells. J Immunol 144: 4477
Sadler TE, Castro JE (1976) The effects ofCorynebacterium parvum and surgery on the Lewis lung carcinoma and its metastases. Br J Surg 63: 292
Salup RR, Herberman RB, Chirigos MA, Back T, Wiltrout RH (1985) Therapy of peritoneal murine cancer with biological response modifiers. J Immunopharmacol 7: 417
Sato T, Takusagawa K, Asoo N, Kumano N, Hasuike M, Konno K (1989) Conversion of Lewis lung carcinoma into ascitic form. Oncology 46: 188
Sheid B (1992) Angiogenic effects of macrophages isolated from ascitic fluid aspirated from women with advanced ovarian cancer. Cancer Lett 62: 153
Sneed RA, Stevenson AP, Stewart CC (1989) Quantitation of the host cell infiltration kinetics of the nonimmunogenic colon 26 tumor by multiparameter flow cytometry. J Leukocyte Biol 48: 547
Snodgrass MJ, Morahan PS, Kaplan AM (1975) Histopathology of the host response to Lewis lung carcinoma: modulation by pyran. J Natl Cancer Inst 55: 455
Springer T, Galfre G, Secher DS, Milstein C (1979) Mac-1: a macrophage differentiation antigen identified by a monoclonal antibody. Eur J Immunol 9: 301
Talmadge JE, Maluish AE, Collins M, Schneider M, Herberman RB, Oldham RK, Wiltrout RH (1984) Immunomodulation and antitumor effects of MVE-2 in mice. J Biol Response Mod 3: 634
Watson GA, Fu XY, Lopez DM (1991) Splenic macrophages from tumor-bearing mice co-expressing Mac-1 and Mac-2 antigens exert immunoregulatory functions via two distinct mechanisms. J Leukocyte Biol 49: 126
Young MR, Newby M (1986) Differential induction of suppressor macrophages by cloned Lewis lung carcinoma variants in mice. J Natl Cancer Inst 77: 1255
Young MR, Wheeler E, Newby M (1986) Macrophage-mediated suppression of natural killer cell activity in mice bearing Lewis lung carcinoma. J Natl Cancer Inst 76: 745
Yurochko AD, Pyle RH, Elgert KD (1989) Changes in macrophage populations: phenotypic differences between normal and tumor bearing host macrophages. Immunobiology 178: 416
Yurochko AD, Burger CJ, Elgert KD (1990) Two-color flow cytometric analysis of the expression of Mac and MHC class II antigens on macrophages during tumor growth. Cytometry 11: 725
Zicari A, Lipari M, Di Renzo L, Longo A, Antonelli G, Pontieri GM (1992) In vivo and in vitro macrophage activation induced by IFN gamma spontaneously released by spleen cells from tumor-bearing mice. J Biol Regul Homeost Agents 6: 65
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Barth, M.W., Morahan, P.S. Role of macrophages in the host response to Lewis lung peritoneal carcinomatosis. Cancer Immunol Immunother 38, 233–242 (1994). https://doi.org/10.1007/BF01533514
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01533514